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Abstract
Background: Supplement use by athletes is complex and research supports the alarming notion
of misinformed decisions regarding supplements.
Hypothesis: A frequent divergence between the type of supplements chosen by athletes and the
rationale dictating the supplement use is hypothesized. Thus, a potentially dangerous incongruence
may exist between rationale and practice.
Testing the hypothesis: In the continued absence of reliable data on supplement use, an
alternative approach of studying the reasons underlying supplement use in athletes is proposed to
determine whether there is an incongruence between rationale and practice. Existing data from
large scale national surveys can be used to investigate this incongruence.
Implications of the hypothesis: In this report, analyses of distinctive patterns between the use
and rationale for use of supplements among athletes are recommended to explore this potentially
dangerous phenomenon.
Background
'Supplement' is an overarching name for vitamins, miner-
als, herbal remedies, traditional Asian remedies, amino
acids and other substances to be taken orally. They may
also be referred to as dietary, food or nutritional supple-
ments or ergogenic aids (supplements purported to
improve athletic performance) and are typically sold in
the form of tablets, capsules, soft gels, liquids, powders,
and bars. In the UK, most supplements are regulated as
foods and subject to the general provisions of the Food
Safety Act 1990, the Food Labelling Regulations 1996 and
the Trade Descriptions Act 1968. Supplements are not
required to exhibit efficacy before marketing, nor are they
subject to prior approval unless they are genetically mod-
ified or claimed to be new. Medicinal claims on packaging
or in an advertisement for a supplement, however, are
prohibited.
Widespread debate has accompanied the introduction of
new legislation on the use of dietary supplements within
the EU. Comprehension of detailed studies, ranging from
quantities and patterns of use to side-effects of supple-
ment consumption, has been impeded by variations in
terminology and practice amongst countries and user
groups. Some thirty thousand supplements are commer-
cially-available in the USA [1] with approximately half of
the adult female population being regular users [2-4],
with possible adverse effects of unregulated supplement
use on health and disease outcomes being of particular
interest [1].
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For some 50 years, competitive sports have operated
under strict regulation, and adherence to the ever-growing
list of prohibited substances [5] is expected from all high
performing athletes at all times. Gaining competitive
advantage, however, is more important than ever. Per-
sonal satisfaction as well as the athletes' livelihoods and
their organisations' prosperity depend on success. Ath-
letes naturally turn to supplements hoping to find herbs,
vitamins or minerals that provide the desired competitive
edge.
Worldwide supplement use among athletes, on average,
ranges between 40 and 60 percent [6-12]. Nutritional sup-
plements are typically used for their actual or anecdotal
physiological effects in increasing performance and
endurance, health maintenance or preventing injuries
[13-16], and the extent and amount of ergogenic 'drugs'
and supplements used by athletes shows a growing trend
[17]. Research linking supplement use to involvement in
physical activity and previous studies on decision making
patterns among these groups has focused on user sub-
group classifications [18-23]. While this enables an under-
standing of the gross difference in the patterns of use
between groups of users, it fails to give an explanation for
why those differences might occur. One key understudied
aspect is a potential mismatch between the decision mak-
ing and execution in practice.
Numerous factors can be involved in athletes' decisions to
use supplements including desired end points such as
increasing strength, endurance, training duration and
overcoming injury as well as avoiding sickness and com-
pensating for poor diet. Unfortunately, lack of knowledge
and/or misconceptions regarding supplements within
athlete populations have been documented for more than
a decade [21,24-27]. Recent research also shows that ath-
letes are willing to take supplements based on personal
recommendation without gathering reliable information
about the substances, often obtaining them directly from
retailers and internet sites [28,29]. Adolescents are more
willing to take supplements obediently if they are
informed by their parents/guardians, as opposed to by
coaches or resulting from published research [30].
Conflicting reports on knowledge levels within health
care professions demonstrate a wide variation in practice.
In one study, physicians and medical students were tested
to determine the level of their knowledge regarding effi-
cacy and toxicity, and drug interactions with herbal reme-
dies, and it was found that the mean test scores were only
slightly higher than scores obtained from random guess-
ing [31]. On the contrary, recent research among physi-
cians, nurses, nutritionists and pharmacists showed
adequate knowledge (average 66% on the knowledge
test), less confidence (55%) but noted a serious lack of
communication skills (average 2.2 out of 10) regarding
herbs and nutritional supplements [32]. Athletic trainers
and coaches were found to be reasonably knowledgeable,
especially those working with female athletes and/or hav-
ing more than 15 years of experience [33].
Supplement types and undesirable 
consequences
A central issue in researching supplement use is the pau-
city of regulatory control of supplement providers cou-
pled to a poor understanding within the user community.
However, in broad terms many supplements have been
associated, rightly or wrongly, with performance enhance-
ment and/or health maintenance [10,15,34-37] includ-
ing: caffeine, ephedrine, creatine, whey protein,
antioxidants, ginseng, multivitamins, vitamin C, iron,
Echinacea and magnesium supplements. To illustrate the
complexities of studying this field, some thirty thousand
individual commercially-available supplements exist [1]
and over 60 supplements were listed in a recent UK survey
[38], summarised in Table 1.
Beyond contaminated products that easily lead to adverse
results in doping tests [8,39-45], vitamin products with
accurately listed compounds and substances can also be
harmful. High levels of vitamin and mineral intake can
lead to toxic side effects [10,35]. For example, the use of
iron supplementation by elite athletes is not uncommon
and whilst iron is beneficial for athletes with iron defi-
ciency, it can also cause harm with long-term use [46] or
certain medical conditions [47]. Similarly, excess intake of
vitamin C [48] can be harmful as well as in combination
with iron, which may cause damage to the gastrointestinal
tract (GI) and initiate or aggravate symptoms associated
with chronic GI disorders [49]. The long-term effects of
creatine are still unknown but short term side-effects such
as cramping and dehydration have been reported along
with the suggestion for its use to be under medical super-
vision [50]. Caffeine is no longer on the list of the IOC's
prohibited substances [53]. However, as athletes can use
it in training and competition, the relationship between
caffeine intake and resulting side-effects such as high
blood pressure warrant further study [52,53]. Whilst the
controversial natural stimulant, ephedrine, has a thresh-
old (concentration in the urine exceeds 10 μg/ml) for con-
sideration for doping [51], the serious harm, which may
be caused by ephedrine is well documented [53-55] and
the direct evidence eventually led to a ban on ephedrine
in 2004 by Food and Drug Administration (FDA), USA.
While the use of blood doping and erythropoietin (EPO)
are prohibited, cobalt is not included in the World Anti
Doping Association's list of prohibited substances [5].
Cobalt produces similar effects to hypoxia and results inPage 2 of 6
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ance but such practice may be harmful [56].
The aim of this report is to highlight the difficulties
involved in generating accurate data on supplement use
and abuse in the absence of rigorous regulatory control. A
new approach is proposed to break through the conun-
drum presented by this 'catch 22' situation. Thus, estab-
lishing motive-use relationships for supplements, should
inform more beneficial use including the elimination of
adverse side-effects.
A frequent divergence between the type of supplements
chosen by athletes and the rationale dictating the supple-
ment use is hypothesized. Thus, a potentially dangerous
incongruence may exist between rationale and practice.
Testing the hypothesis
Congruence between rationale and supplements used by
athletes can be investigated by analyzing quantitative or
qualitative data. Although qualitative approaches have
the advantage of producing deep understanding of ath-
letes' motivations, data from these studies are not suitable
for hypothesis testing. Results from quantitative analyses,
assuming adequate sampling and appropriate statistical
analyses are objective and comparable. Data from this
type of research are normally collected via surveys or
structured interviews. Due to the ever present probability
of response bias, the use of an anonymous questionnaire
is preferable over face to face interviews [57]. The fact that
socially desirable responding increases as the sensitivity of
the issue being investigated increases [58] should also be
taken into consideration.
A sample is recommended to be drawn from a wide cross-
section of the athlete population with adequate data in
each subgroup of interest. The minimum required sample
size depends on the effect size and power of the test [59]
but usually is in the magnitude of hundreds in total with
a minimum of 20–25 per subgroup in case of continuous
variables [60] and a minimum of 5 observed cell frequen-
cies in cross classified categorical variables [61].
Empirical data collection regarding supplement use
among athletes can be prospective or retrospective. Retro-
spective studies collect information about the past and
relies on the recollection of events whilst other studies
investigate the present or follow participants over the
period of time in longitudinal studies. A longitudinal
research design is useful when a change over time is
important. This would be especially relevant in research
aimed to investigate decision making patterns and influ-
ences regarding the use of ergogenic aids. Alternatively,
one may attempt to derive the same results from a cross-
sectional design. However, results are only valuable if data
obtained from different age groups adequately represent
natural progression over time, thus employing the appro-
priate sampling method is critical.
Prospective studies have the advantage of using tailored
research design and methods with the specific research
question in mind. The level of measurement needed for
specific analytical procedures and the statistical power-
effect size-sample size triangle (if known) can also be
given a priori consideration. Published studies may be
used as pilot studies for estimating effect size and power,
hence determining the minimum sample size required for
noteworthy research.
In parallel to the increase in computational power, an
increasing number of studies utilise existing data that
might or might not be collected for the specific research
purpose. The least uncomplicated method is re-analyzing
existing data to test a new set of hypotheses. At the other
end of the spectrum, data mining allows researchers to
derive important and previously undiscovered but poten-
tially useful information from large volumes of data using
automated searching for meaningful and significant pat-
terns. Prime examples for these types of studies are
research projects relying on integrated clinical databases,
Table 1: Supplements taken by high performance UK athletes (in alphabetical order)
Listed by product/brand names Listed by components/contents
Ache Free, Cyclone, Build Up, Green Magic, Herbalife, Hydroxycut, 
Immune Support, Kalms, Lactibiane, Leppin, Lucozade, Met-Rx, Minadex, 
Mega EPA, MSN, Multibionta, Musashi Protein, Qlo, Slim Fast, 
SportsFlex, Vitabalance
Aloe Vera, Alpha-lipoic Acid, Amino Acids, Arnica, Black strap molasses, 
Calcium, Calendula, Carbohydrate & recovery drinks, C-Glutamine, 
Chinese Tea, Chromium, Chondroitin, CLA (conjugated linoleic acid), 
Cod liver oil, Coenzyme Q10, Colostrum, Cranberry juice tablets, 
Digestive enzymes, Dried skimmed milk powder, Echinacea tea bags, 
Electrolytes, Evening primrose oil, Ferrous gluconate, Fish oils, Flax seed 
oil, Folic acid, Garlic capsules, Glucosomine, Harpagophytum 
procumbens, Hydroxybetamethylbutyrate, L-Carnitine, L-Glutamine, 
Maitake mushroom, Matltodextrin/Aspartame, meal replacement, Multi 
Mineral Supplements, Olbas Oil, Protein drinks, Selenium, Soya protein, 
Starflower oil, Sumpast, Tribulous Terrestris, Vitamin B, B combined 
with Forceval capsules, Vitamin B complex, Vitamin D and E, ZincPage 3 of 6
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trally held statistical information on populations. Con-
trary to data mining that requires raw data, meta analysis
combines the results of published studies that address the
same research question. Although meta analysis is widely
used in epidemiological and evidence-based medical
studies in order to increase statistical power, this approach
is problematic in nutritional supplement research due to
the lack of sufficient regulations of the supplement mar-
ket. These problems are well illustrated in recent meta
analyses of antioxidant supplement use for cancer preven-
tion and their effects on mortality [62]. Declared interest
and publication bias (i.e., non-significant results are sel-
dom published) should also be taken into account when
one attempts meta analyses of supplement use, effects and
side effects in athletes.
Considering the costs of research and data collection,
especially when a large data set is required, multiple uses
of data facilitates a better use of public funds, hence it
should be encouraged. However, whether it is a hypothe-
sis driven statistical analysis or structured/unstructured
data mining, results from subsequent analyses should
contribute to the understanding of the phenomenon. In
this case, results must add to the body of knowledge
regarding supplement use and rationale in elite athletes.
Proposed approach
Existing data sets that include both 'supplements' and
'rationale/knowledge' variables can be used to obtain evi-
dence regarding athletes' potentially dangerous, incongru-
ent behaviour. Rationale or knowledge can also be
replaced by behavioural intention (if reasons for use are
specified) or beliefs about particular substances. Practi-
cally, any data that allow a scientifically and statistically
meaningful contingency table to be formed are suitable
for such analyses. It is suggested that existing, recent,
large-scale national surveys conducted among adult and
adolescent athletes by national level sport organisations
and governing bodies should be scrutinised to test the
hypothesis regarding supplement use in sports.
By creating a series of two by two contingency tables from
cross-tabling each supplement intake categories and rea-
sons for supplement use, we can:
i) test for relationships between answers (i.e., testing for
independence of the two variables);
ii) estimate the strength of this relationship from the pro-
portion of congruent pairs of answers (reasons given for
supplement use matches with the reported supplement
use);
iii) calculate the relative proportion of answers indicating
informed choices and incongruent answers (reasons given
for supplement use are not followed by the appropriate
supplement) and compare the observed pattern of supple-
ment use to an expected pattern; and
iv) test whether this pattern characterises the athlete pop-
ulation.
A pair of answers is congruent if there is an agreement
between an athlete's self-reported supplement use and
rationale. The connection is not explicitly made by the
athlete but calculated afterwards from answers given on
two separate and seemingly independent questions. In
surveys of supplement use, athletes are often asked about
the substances they have had experience with and some of
these surveys also contain explicit questions regarding the
reasons behind supplement taking [9,12,21,38,63]. Table
2 illustrates a simplified scenario of one particular reason
for supplementing and the corresponding substance. For
instance, a group of athletes were asked: i) whether they
use supplements to increase their strength and power out-
put; and ii) if they take creatine – a substance known for
this effect [10] and currently not sanctioned in competi-
tive sport. Answer options to both questions were limited
to dichotomous (Yes/No) responses, thus its contingency
table is a two-by-two square. Assume that exactly 100 ath-
letes were asked and 75 (%) of them take supplements to
maintain or increase strength. In an ideal case when all
athletes make an informed and rational decision about
supplements, we would expect X to be 75 and W to be 25,
whereas both Y and Z should be zero. This {75, 0, 25, 0}
is the expected pattern under the assumption of the fully
informed choice. On the contrary, a pattern of X = 0, Z =
75, Y = 25 and W = 0 would indicate a great deal of con-
fusion or complete misinformation about supplements
and their physiological effects.
However, in real life it is not likely that we can observe a
perfect pattern, thus we use appropriate statistical analyses
[60] to determine whether the observed pattern signifi-
cantly differs from: i) what is expected; or ii) what would
happen by random chance if we assume that the two ques-
tions are unrelated. Descriptive statistics obtained from
the sample are very interesting and informative but no
inferences can be made to the population from which the
sample was drawn.
For example, we assume that protein use is common
among professional male players from sports where
strength is important. In the UK Sport survey [38] 186
male professional players indicated supplement use, of
which 106 (57%) listed and 87 (47%) used whey protein.
Simple descriptive statistics (frequency and percentage by
variables) do not tell us whether the group of 106 playersPage 4 of 6
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reported the use of whey protein. Therefore, using chi-
square tests of association and phi coefficients offer a bet-
ter approach to delineate athletes' informed choices by
considering the two variables (reason for use and supple-
ment used) simultaneously. In this example, the test
results shows significant (χ2 = 44.28, p < .001) and rela-
tively strong (phi = .49, p < .001) associations between
whey protein use and the reason 'maintaining strength' in
athletes' answers suggesting that athletes make informed
choice regarding strength and protein use. Re-creating the
contingency table given in Table 2, shows that X = 72
(68%), W = 65 (81%), Y = 15 (19%) and Z = 34 (32%),
where ΣXZ and ΣWY are 100%. Comparing these cells to
the expected pattern under the assumption of the fully
informed choice {106,0,80,0}, we see that: i) 68 % those
who wish to maintain strength are taking whey protein
and the observed pattern differs significantly from the
expected pattern of the fully informed choice (χ2 = 10.9, p
= .001); and ii) 81% of those who are not interested in
maintaining strength are not taking protein either and it
confirms to the expected pattern (χ2 = 2.81, p = .094).
The result from the above example is not surprising as
protein is a fairly well-known and widely used supple-
ment but the analyses of other substances may not show
the same level of confidence. Statistical procedures pro-
posed here (i.e., tests of independence and strength of
association) provide evidence that the phenomenon
directly evidenced in the sample is observable in the pop-
ulation as well. Because surveys are normally not limited
to a sole reason and a single substance, such an approach
also allows comparison of strength of associations across
supplement categories and reasons.
Implications of the hypothesis
In order to regulate the European market, the European
Union (EU) issued the Food Supplements Directive 2002/
46/EC, which was implemented in the UK in 2003, effec-
tive from August 2005 [64]. The Food Standards Agency
has successfully rebutted the EU's attempt and, by virtue
of the derogation in Article 4.6. of the Directive, which
permits the continued use of vitamins and minerals not
on the 'positive lists', the UK supplement market will
remain semi-regulated at least until 2009 [65]. Unless
clear evidence is found for adverse effects, health warnings
are therefore not likely to be placed on nutritional supple-
ments [9]. Thus, widespread supplement use is likely to
remain at a high level or to increase further. The conun-
drum is obtaining the strong evidence in the absence of
regulation which severely limits the validity of clinical
investigations.
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